Stronger Sell Today ALXN ranks #4350 as SELL CANDIDATE #4350 Weaker Sell

ALXN stock forecast Alexion Pharmaceuticals

ALXN stock forecast

VOLUME
Buy
TREND
Sell
MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Sell

ALXN Forecast and Technical Stock Analysis

Sell candidate since 2019-07-18 Loss -2.00%

Alexion Pharmaceuticals fell by -2.00% in the last day ( Friday, 19th Jul 2019 ) from $123.26 to $120.80 and has now fallen 3 days in a row. During day the stock fluctuated 2.84% from a day low at $120.77 to a day high of $124.20. The price has fallen in 7 of the last 10 days and is down by -7.29% for this period. Volume has increased in the last day by 0.38 million shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.47 million shares bought and sold for approximately $177.82 million.

Quick summary:

  • 30 day high of the ALXN stock price was $134.84 and low was $119.53.
  • 90 day high was $137.52 and low was $112.86.
  • 52 week high for the Alexion Pharmaceuticals - $141.86 and low - $92.56.
Top Trending Stocks

Trend

Alexion Pharmaceuticals lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -6.95% during the next 3 months and, with 90% probability hold a price between $100.74 and $122.98 at the end of this period.

Top Golden Star Stocks

Signals

There are few to none technical positive signals at the moment. Alexion Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $122.23 and $123.22. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Wednesday July 17, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 28 and the stock is currently not being overbought or oversold

* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Support & Resistance

Alexion Pharmaceuticals finds support from accumulated volume at $118.81.

Support: $118.81 Price: $120.80 Resistance: $128.83

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $3.43 (2.84%) between high and low. For the last week, the stock has had a daily average volatility of 2.19%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

2.19 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Sell Candidate Downgraded

Evaluation

Alexion Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Stronger Sell Today ALXN ranks #4350 as SELL CANDIDATE #4350 Weaker Sell

Will ALXN stock price go up or down on Mon, 22 Jul 2019?

Predict
Trading With Moving Average
As an investor, you always seek to understand what other... Full Article
Pivot Points
Pivot Points refer to points of significant change. As a... Full Article
Accumulated Volume - Support and Resistance
Volume is perhaps the best indicator of all and should... Full Article
Volume - The Indicator You Really Need to Know
Many new traders getting into the world of technical analysis... Full Article
We Give Back!
In 2016 StockInvest.us donated to NGO Goodwill projects to help purchase medical... Full Article
Better Buy: Amazon vs. Facebook
Amazon's stock slipped 21% over the past six months, as... Full Article

Proudly made at

ROCKIT